-
-
-
-
-
-
-
U.S. Biotech stocks: Q1 earnings previews
-
-
-
-
-
-
-
Baird Reiterates Outperform Rating on Biogen (BIIB)
-
-
-
-
-
-
-
HSBC highlights one pharma stock to buy and one to sell for 2026
-
-
-
-
-
-
-
Biotech stocks: Q3 earnings preview
-
-
-
-
-
-
-
These 30 global stocks offer tactical and structural upside, says RBC
-
-
-
-
-
-
-
Biogen (BIIB) Tops Q4 EPS by 3c; offers outlook
-
-
-
-
-
-
-
Biogen raises annual earnings guidance, tops Q3 estimates; shares up
-
1,199,948 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

